cGMP Enhancing Therapeutic Strategy for HFpEF: The cGETS Study An interventional, single blind, multicentre study.

Trial Profile

cGMP Enhancing Therapeutic Strategy for HFpEF: The cGETS Study An interventional, single blind, multicentre study.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Mar 2018

At a glance

  • Drugs Atorvastatin (Primary) ; Lisinopril (Primary) ; Rosuvastatin (Primary) ; Tadalafil (Primary) ; Candesartan cilexetil; Nebivolol; Perindopril; Ramipril; Simvastatin; Sitagliptin
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms cGETS
  • Most Recent Events

    • 07 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top